Oriflame assesses novel active as safe in cosmetics in-line with EU requirements

By Andrew MCDOUGALL

- Last updated on GMT

Oriflame assesses novel active as safe in cosmetics in-line with EU requirements

Related tags Cosmetics

Oriflame’s Ireland operation has assessed acetyl aspartic acid (AAA) as safe for use in all cosmetics products at a level of 5%, using a new cosmetic safety assessor in line with the requirements of the EU Cosmetics Regulation and in accordance with the SCCS notes of guidance.

Previous research carried out by the cosmetics manufacturer characterised the anti-ageing potential of AAA and it has been proposed as a novel active ingredient for use in cosmetics

The safety of the active was assessed by following an in-house-developed ‘New Ingredient Testing Strategy’, which built a safety profile for AAA, comprising of a detailed literature and data bank search, in vitro safety testing, margin of safety (MoS) calculation and human compatibility testing.

The aim of this is to provide a library of safe ingredients, and where required, to remove potentially unsafe ingredients at the earliest opportunity to prevent further investment in the research phase.

Having performed this, the Oriflame team, made up of Paul Daly and Garrett Moran, says: “Taking into account all of the information, the ‘New Ingredient Testing Strategy’ has been proven to be an effective approach for assessing the safety of AAA in this instance.”

“This strategy allows the safety assessor to meet the stringent requirements of the EU Cosmetics Regulation and to overcome the challenges presented by the animal testing ban.”

Assessment

The team conducted its research by starting with a literature review of over 40 different information sources​, to highlight a number of gaps which required testing data.

From this, AAA was tested for photo-toxicity according to OECD test guideline 432, skin irritation according to OECD test guideline 439 and eye irritation according to OECD test guideline 437.

Dermal absorption of the ingredient was also measured according to OECD test guideline 428 and was used to calculate the MoS, before it was tested in a human repeat insult patch test (HRIPT) and a 14-day in-use tolerance study.

These tests found that AAA was non-phototoxic and was non-irritating to skin and eyes in in vitro testing, while dermal absorption was calculated to be 5%.

The MoS was 351, at a level of 5%, for all cosmetic product types, indicating no systemic safety toxicity concern, and repeated application to the surrounding eye area, twice a day for 14 days, in 21 female volunteers, demonstrated that 1% AAA was well tolerated.

Requirement

The safety of finished cosmetic products must meet the legal requirements of the EU Cosmetics Regulation and the safety of the new ingredient should be assessed in line with the guidelines of the SCCS.

Over the past decade, the cosmetic industry has had to adapt to the introduction of more stringent regulations and to the implementation of the animal testing ban.

To adapt to these changes, cosmetic companies need to have experienced cosmetic safety assessors to certify the safety of their products and need to design alternative testing strategies to overcome the challenges of the animal testing ban.

Related news

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us

Products

View more

Webinars

Podcast

Beauty 4.0 Podcast